Table of contents

Volume 87, Issue 1
Published online 25 June 2002 (1-128)

Top

Clinical

Does training increase the use of more emotionally laden words by nurses when talking with cancer patients? A randomised study FREE

D Razavi, N Delvaux, S Marchal, J-F Durieux, C Farvacques, L Dubus and R Hogenraad

Br J Cancer 87: 1-7; doi:10.1038/sj.bjc.6600412

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index FREE

R A Hawkins, A L Tesdale, R J Prescott, T Forster, M A McIntyre, P Baker, W J L Jack, U Chetty, J M Dixon, M E Killen, M J Hulme and W R Miller

Br J Cancer 87: 8-14; doi:10.1038/sj.bjc.6600335

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer FREE

K J O'Byrne, A L Thomas, R A Sharma, M DeCatris, F Shields, S Beare and W P Steward

Br J Cancer 87: 15-20; doi:10.1038/sj.bjc.6600344

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes FREE

N Tsavaris, C Kosmas, M Vadiaka, P Kanelopoulos and D Boulamatsis

Br J Cancer 87: 21-27; doi:10.1038/sj.bjc.6600347

Top

Epidemiology

Reduced risk of synovial sarcoma in females: X-chromosome inactivation? FREE

X Bu, L Bernstein and R K Brynes

Br J Cancer 87: 28-30; doi:10.1038/sj.bjc.6600362

A prospective cohort study of soy product intake and stomach cancer death FREE

C Nagata, N Takatsuka, N Kawakami and H Shimizu

Br J Cancer 87: 31-36; doi:10.1038/sj.bjc.6600349

Dietary factors and stomach cancer mortality FREE

L T Ngoan, T Mizoue, Y Fujino, N Tokui and T Yoshimura

Br J Cancer 87: 37-42; doi:10.1038/sj.bjc.6600415

Recent trends and future directions for lung cancer mortality in Europe FREE

P Brennan and I Bray

Br J Cancer 87: 43-48; doi:10.1038/sj.bjc.6600352

Aspirin and lung cancer in women FREE

A Akhmedkhanov, P Toniolo, A Zeleniuch-Jacquotte, K L Koenig and R E Shore

Br J Cancer 87: 49-53; doi:10.1038/sj.bjc.6600370

Does place of birth influence endogenous hormone levels in Asian-American women? FREE

R T Falk, T R Fears, R N Hoover, M C Pike, A H Wu, A M Y Nomura, L N Kolonel, D W West and R G Ziegler

Br J Cancer 87: 54-60; doi:10.1038/sj.bjc.6600339

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study FREE

T Bjørge, A Engeland, T Luostarinen, J Mork, R E Gislefoss, E Jellum, P Koskela, M Lehtinen, E Pukkala, SØ Thoresen and J Dillner

Br J Cancer 87: 61-64; doi:10.1038/sj.bjc.6600350

Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96 FREE

E Paci, S W Duffy, D Giorgi, M Zappa, E Crocetti, V Vezzosi, S Bianchi and M Rosselli del Turco

Br J Cancer 87: 65-69; doi:10.1038/sj.bjc.6600301

Top

Molecular and Cellular Pathology

Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients FREE

I de Mascarel, G MacGrogan, V Picot and S Mathoulin-Pelissier

Br J Cancer 87: 70-74; doi:10.1038/sj.bjc.6600420

High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum FREE

M A E Nobbenhuis, T J M Helmerhorst, A J C van den Brule, L Rozendaal, P D Bezemer, F J Voorhorst and C J L M Meijer

Br J Cancer 87: 75-80; doi:10.1038/sj.bjc.6600367

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters FREE

J Watanabe, H Sato, T Kanai, Y Kamata, T Jobo, H Hata, T Fujisawa, E Ohno, T Kameya and H Kuramoto

Br J Cancer 87: 81-85; doi:10.1038/sj.bjc.6600434

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours FREE

G H Hall, L W Turnbull, I Richmond, L Helboe and S L Atkin

Br J Cancer 87: 86-90; doi:10.1038/sj.bjc.6600284

Increased expression of survivin in gastric cancer patients and in first degree relatives FREE

J Yu, W K Leung, M P A Ebert, E K W Ng, M Y Y Go, H B Wang, S C S Chung, P Malfertheiner and J J Y Sung

Br J Cancer 87: 91-97; doi:10.1038/sj.bjc.6600421

Top

Experimental Therapeutics

Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis FREE

P Giridharan, S T Somasundaram, K Perumal, R A Vishwakarma, N P Karthikeyan, R Velmurugan and A Balakrishnan

Br J Cancer 87: 98-105; doi:10.1038/sj.bjc.6600422

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes FREE

C Marty, B Odermatt, H Schott, D Neri, K Ballmer-Hofer, R Klemenz and R A Schwendener

Br J Cancer 87: 106-112; doi:10.1038/sj.bjc.6600423

Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling FREE

B van't Land, H P Meijer, J Frerichs, M Koetsier, D Jager, R L Smeets, L M'Rabet and M Hoijer

Br J Cancer 87: 113-118; doi:10.1038/sj.bjc.6600342

Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor FREE

W Shi and D W Siemann

Br J Cancer 87: 119-126; doi:10.1038/sj.bjc.6600416

Top

Book Review

Epstein-Barr Virus and Human Cancer FREE

Lawrence Young

Br J Cancer 87: 127-128; doi:10.1038/sj.bjc.6600427

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT

naturejobs